社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
ACKW
IP属地:未知
+关注
帖子 · 20
帖子 · 20
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
ACKW
ACKW
·
2021-12-17
hopefully before year end
WHO and EMA could approve Novavax Covid vaccine next week
US drugmaker ‘confident’ as health bodies signal decisions are on the horizon Medical laboratory sci
WHO and EMA could approve Novavax Covid vaccine next week
看
963
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-07-22
hi
@ACKW:
hi
hi
看
559
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-07-22
hi
Cryptocurrency-related stocks soar in premarket trading
(July 22) Cryptocurrency-related stocks soar in premarket trading. Bitcoin rose 1% from its 5 p.m. E
Cryptocurrency-related stocks soar in premarket trading
看
568
回复
评论
点赞
4
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-06-08
Is it a VPN?
非常抱歉,此主贴已删除
看
565
回复
1
点赞
1
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-25
squeezy squeezy
非常抱歉,此主贴已删除
看
370
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-17
$SINGAPORE AIRLINES LTD(C6L.SI)$
red day?
看
442
回复
评论
点赞
2
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-10
Up up
看
349
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-06
This is bad.
非常抱歉,此主贴已删除
看
1,021
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-05
everybody hopping back into semicon again
非常抱歉,此主贴已删除
看
577
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
ACKW
ACKW
·
2021-05-05
self lyfting
LYFT rose nearly 7% in pre-market
LYFT rose nearly 7% in pre-market. Lyft Inc. on Tuesday posted quarterly results that reflect what i
LYFT rose nearly 7% in pre-market
看
413
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581924035780170","uuid":"3581924035780170","gmtCreate":1618830011466,"gmtModify":1618830011466,"name":"ACKW","pinyin":"ackw","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":690713103,"gmtCreate":1639708116504,"gmtModify":1639709044802,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"hopefully before year end","listText":"hopefully before year end","text":"hopefully before year end","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690713103","repostId":"1116963836","repostType":2,"repost":{"id":"1116963836","kind":"news","pubTimestamp":1639696910,"share":"https://www.laohunote.com/m/news/1116963836?lang=&edition=full","pubTime":"2021-12-17 07:21","market":"us","language":"en","title":"WHO and EMA could approve Novavax Covid vaccine next week","url":"https://stock-news.laohu8.com/highlight/detail?id=1116963836","media":"Financial Times ","summary":"US drugmaker ‘confident’ as health bodies signal decisions are on the horizon\nMedical laboratory sci","content":"<p>US drugmaker ‘confident’ as health bodies signal decisions are on the horizon</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a0574d3e2d27c0558f362139853e66b6\" tg-width=\"700\" tg-height=\"394\" width=\"100%\" height=\"auto\"><span>Medical laboratory scientist Aniela Sobel tests serology samples from the Novavax phase 3 clinical trial in Seattle, Washington © Karen Ducey/Getty</span></p>\n<p>The approvals would provide the US drugmaker with a significant boost after months of delays and share price volatility amid manufacturing issues. The Covid-19 vaccine, also known as Nuvaxovid, would be the Maryland-based company’s first marketed product after more than three decades in business.</p>\n<p>A meeting of an EMA panel has been scheduled for Monday, the agency said, adding that it would communicate more details on that day provided there was a conclusion.</p>\n<p>Separately, the WHO’s expert panel on vaccines met on Thursday to draft recommendations for use of the vaccine, with the WHO saying it would release its position “in the coming days”.</p>\n<p>WHO approval could come once the health body issued its own emergency use listing, or if the EMA gave it a conditional marketing authorisation, people familiar with the matter said.</p>\n<p>The step would allow deliveries to begin via global vaccine access scheme Covax. Together with the Serum Institute of India, Novavax has a commitment to supply Covax with 1.1bn doses.</p>\n<p>Two people familiar with both approval processes said there were still some “open questions” on manufacturing, but that the EMA should be able to issue a conditional approval. The open questions include so-called potency assays and drug substance characterisation — in essence, the ability of Novavax to ensure the product is the same everywhere and the same as that used in clinical studies.</p>\n<p>The people said Novavax had acknowledged these points in meetings and was working to address them.</p>\n<p>“It’s nothing serious. It’s not different from situations we have seen with previous vaccines,” one of the people said, while also cautioning that an approval was not certain.</p>\n<p>Novavax said both approval processes would consider extensive data on manufacturing as well as clinical and pre-clinical data. The company was “confident that the vaccine meets the stringent regulatory quality, safety and efficacy specifications” needed for authorisation by the WHO and the EMA and it looked forward to their decisions.</p>\n<p>The EMA declined to comment. The WHO said it would release its position “in the coming days”.</p>\n<p>One of the people added that the EMA was “racing against time” as the vaccine, which would initially only be approved for a primary series or the first two shots for someone who has not been vaccinated, could play “an important role” this winter.</p>\n<p>The Novavax shot has already been approved in the Philippines and Indonesia and the drugmaker has filed for approval in the UK. The company also expects to submit a complete application to the US Food and Drug Administration by year’s end.</p>\n<p>In contrast to the novel mRNA vaccines made by Moderna and Pfizer, the Novavax shot uses a more traditional type of technology based on proteins and has been shown to be as much as 90.4 per cent effective in trials, including against previous variants of concern. The company is now testing its efficacy against the new Omicron variant.</p>","source":"lsy1580170736413","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WHO and EMA could approve Novavax Covid vaccine next week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWHO and EMA could approve Novavax Covid vaccine next week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 07:21 GMT+8 <a href=https://www.ft.com/content/a938950e-7f97-46d6-a22c-6933c5634842><strong>Financial Times </strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>US drugmaker ‘confident’ as health bodies signal decisions are on the horizon\nMedical laboratory scientist Aniela Sobel tests serology samples from the Novavax phase 3 clinical trial in Seattle, ...</p>\n\n<a href=\"https://www.ft.com/content/a938950e-7f97-46d6-a22c-6933c5634842\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.ft.com/content/a938950e-7f97-46d6-a22c-6933c5634842","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116963836","content_text":"US drugmaker ‘confident’ as health bodies signal decisions are on the horizon\nMedical laboratory scientist Aniela Sobel tests serology samples from the Novavax phase 3 clinical trial in Seattle, Washington © Karen Ducey/Getty\nThe approvals would provide the US drugmaker with a significant boost after months of delays and share price volatility amid manufacturing issues. The Covid-19 vaccine, also known as Nuvaxovid, would be the Maryland-based company’s first marketed product after more than three decades in business.\nA meeting of an EMA panel has been scheduled for Monday, the agency said, adding that it would communicate more details on that day provided there was a conclusion.\nSeparately, the WHO’s expert panel on vaccines met on Thursday to draft recommendations for use of the vaccine, with the WHO saying it would release its position “in the coming days”.\nWHO approval could come once the health body issued its own emergency use listing, or if the EMA gave it a conditional marketing authorisation, people familiar with the matter said.\nThe step would allow deliveries to begin via global vaccine access scheme Covax. Together with the Serum Institute of India, Novavax has a commitment to supply Covax with 1.1bn doses.\nTwo people familiar with both approval processes said there were still some “open questions” on manufacturing, but that the EMA should be able to issue a conditional approval. The open questions include so-called potency assays and drug substance characterisation — in essence, the ability of Novavax to ensure the product is the same everywhere and the same as that used in clinical studies.\nThe people said Novavax had acknowledged these points in meetings and was working to address them.\n“It’s nothing serious. It’s not different from situations we have seen with previous vaccines,” one of the people said, while also cautioning that an approval was not certain.\nNovavax said both approval processes would consider extensive data on manufacturing as well as clinical and pre-clinical data. The company was “confident that the vaccine meets the stringent regulatory quality, safety and efficacy specifications” needed for authorisation by the WHO and the EMA and it looked forward to their decisions.\nThe EMA declined to comment. The WHO said it would release its position “in the coming days”.\nOne of the people added that the EMA was “racing against time” as the vaccine, which would initially only be approved for a primary series or the first two shots for someone who has not been vaccinated, could play “an important role” this winter.\nThe Novavax shot has already been approved in the Philippines and Indonesia and the drugmaker has filed for approval in the UK. The company also expects to submit a complete application to the US Food and Drug Administration by year’s end.\nIn contrast to the novel mRNA vaccines made by Moderna and Pfizer, the Novavax shot uses a more traditional type of technology based on proteins and has been shown to be as much as 90.4 per cent effective in trials, including against previous variants of concern. The company is now testing its efficacy against the new Omicron variant.","news_type":1},"isVote":1,"tweetType":1,"viewCount":963,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":172121108,"gmtCreate":1626945187204,"gmtModify":1633769503402,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172121108","repostId":"172123555","repostType":1,"repost":{"id":172123555,"gmtCreate":1626945161077,"gmtModify":1633769503746,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/172123555","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":559,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172123555,"gmtCreate":1626945161077,"gmtModify":1633769503746,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"hi","listText":"hi","text":"hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":1,"link":"https://laohu8.com/post/172123555","repostId":"1137753306","repostType":4,"repost":{"id":"1137753306","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626944539,"share":"https://www.laohunote.com/m/news/1137753306?lang=&edition=full","pubTime":"2021-07-22 17:02","market":"us","language":"en","title":"Cryptocurrency-related stocks soar in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1137753306","media":"Tiger Newspress","summary":"(July 22) Cryptocurrency-related stocks soar in premarket trading.\nBitcoin rose 1% from its 5 p.m. E","content":"<p>(July 22) Cryptocurrency-related stocks soar in premarket trading.</p>\n<p>Bitcoin rose 1% from its 5 p.m. ET level, trading around $32,200 and extending gains into a second day. The cryptocurrency rallied Wednesday after Tesla Chief ExecutiveElon Musksaid bothhe and his rocket company SpaceX hold bitcoin.</p>\n<p><img src=\"https://static.tigerbbs.com/72881d44f1f43108ff16826114112776\" tg-width=\"301\" tg-height=\"324\" referrerpolicy=\"no-referrer\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cryptocurrency-related stocks soar in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCryptocurrency-related stocks soar in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-22 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(July 22) Cryptocurrency-related stocks soar in premarket trading.</p>\n<p>Bitcoin rose 1% from its 5 p.m. ET level, trading around $32,200 and extending gains into a second day. The cryptocurrency rallied Wednesday after Tesla Chief ExecutiveElon Musksaid bothhe and his rocket company SpaceX hold bitcoin.</p>\n<p><img src=\"https://static.tigerbbs.com/72881d44f1f43108ff16826114112776\" tg-width=\"301\" tg-height=\"324\" referrerpolicy=\"no-referrer\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1137753306","content_text":"(July 22) Cryptocurrency-related stocks soar in premarket trading.\nBitcoin rose 1% from its 5 p.m. ET level, trading around $32,200 and extending gains into a second day. The cryptocurrency rallied Wednesday after Tesla Chief ExecutiveElon Musksaid bothhe and his rocket company SpaceX hold bitcoin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":568,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117983053,"gmtCreate":1623113477072,"gmtModify":1634036845833,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"Is it a VPN?","listText":"Is it a VPN?","text":"Is it a VPN?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/117983053","repostId":"2141025670","repostType":4,"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138897221,"gmtCreate":1621923909363,"gmtModify":1634185449080,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"squeezy squeezy","listText":"squeezy squeezy","text":"squeezy squeezy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/138897221","repostId":"2138159655","repostType":2,"isVote":1,"tweetType":1,"viewCount":370,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":192275439,"gmtCreate":1621213961321,"gmtModify":1631885598068,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>red day?","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>red day?","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$red day?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/192275439","isVote":1,"tweetType":1,"viewCount":442,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":190714137,"gmtCreate":1620652875729,"gmtModify":1634197407361,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"Up up","listText":"Up up","text":"Up up","images":[{"img":"https://static.tigerbbs.com/ac74ca6a6034f7f7065b0d1e17252cda","width":"1080","height":"1088"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/190714137","isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":105563004,"gmtCreate":1620311520608,"gmtModify":1634206162133,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"This is bad.","listText":"This is bad.","text":"This is bad.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/105563004","repostId":"1164542221","repostType":4,"isVote":1,"tweetType":1,"viewCount":1021,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102625928,"gmtCreate":1620209500864,"gmtModify":1634206978602,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"everybody hopping back into semicon again","listText":"everybody hopping back into semicon again","text":"everybody hopping back into semicon again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102625928","repostId":"2133542910","repostType":4,"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":102622648,"gmtCreate":1620209422484,"gmtModify":1634206979217,"author":{"id":"3581924035780170","authorId":"3581924035780170","name":"ACKW","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581924035780170","authorIdStr":"3581924035780170"},"themes":[],"htmlText":"self lyfting","listText":"self lyfting","text":"self lyfting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/102622648","repostId":"1196017368","repostType":4,"repost":{"id":"1196017368","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1620202840,"share":"https://www.laohunote.com/m/news/1196017368?lang=&edition=full","pubTime":"2021-05-05 16:20","market":"us","language":"en","title":"LYFT rose nearly 7% in pre-market","url":"https://stock-news.laohu8.com/highlight/detail?id=1196017368","media":"Tiger Newspress","summary":"LYFT rose nearly 7% in pre-market.\nLyft Inc. on Tuesday posted quarterly results that reflect what i","content":"<p>LYFT rose nearly 7% in pre-market.</p>\n<p><img src=\"https://static.tigerbbs.com/0009a666271d9b6ab097802d7a92493a\" tg-width=\"1279\" tg-height=\"602\">Lyft Inc. on Tuesday posted quarterly results that reflect what it's been saying for the past couple of months: Ride hailing is back.</p>\n<p>Lyft <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> said it had 13.49 million active riders in the first quarter, an increase of about 940,000 from the previous quarter. Analysts surveyed by FactSet on average had expected 12.8 million.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LYFT rose nearly 7% in pre-market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLYFT rose nearly 7% in pre-market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-05 16:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LYFT rose nearly 7% in pre-market.</p>\n<p><img src=\"https://static.tigerbbs.com/0009a666271d9b6ab097802d7a92493a\" tg-width=\"1279\" tg-height=\"602\">Lyft Inc. on Tuesday posted quarterly results that reflect what it's been saying for the past couple of months: Ride hailing is back.</p>\n<p>Lyft <a href=\"https://laohu8.com/S/LYFT\">$(LYFT)$</a> said it had 13.49 million active riders in the first quarter, an increase of about 940,000 from the previous quarter. Analysts surveyed by FactSet on average had expected 12.8 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LYFT":"Lyft, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196017368","content_text":"LYFT rose nearly 7% in pre-market.\nLyft Inc. on Tuesday posted quarterly results that reflect what it's been saying for the past couple of months: Ride hailing is back.\nLyft $(LYFT)$ said it had 13.49 million active riders in the first quarter, an increase of about 940,000 from the previous quarter. Analysts surveyed by FactSet on average had expected 12.8 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":413,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}